Both in Pharmaceuticals
Latigo Biotherapeutics vs Savara
Over the past year LTGO returned −38.1% and SVRA returned −10.8%; their daily moves had a correlation of 0.33.
LTGO −38.1% SVRA −10.8%Growth of $1, one year, split-adjusted
| Metric | LTGO | SVRA |
|---|---|---|
| Price | $13.72 | $4.73 |
| Market cap | $909.3M | $970.8M |
| Today | −1.68% | −1.97% |
| 1 month | −13.7% | −1.8% |
| 6 months | — | −10.8% |
| Year to date | — | −21.6% |
| 1 year | — | +9.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $142.9M |
| Dividend yield | — | — |
| Volatility (60d) | — | 48.5% |
| Short % of float | 1.6% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).